Yael L. Maxwell
banner
yaelmaxwell.bsky.social
Yael L. Maxwell
@yaelmaxwell.bsky.social
Senior Medical Journalist, Section Editor of Fellows Forum at TCTMD
Mama to two tiny humans
Pinned
I set up a Signal account if anyone would prefer to reach me there.
Reposted by Yael L. Maxwell
TCTMD celebrates its 25th anniversary! Listen to the editorial team reflect on the website's greatest hits over the years. www.tctmd.com/audio/tctmd-...
@yaelmaxwell.bsky.social
@lamckeown1.bsky.social
October 22, 2025 at 7:07 PM
"I felt crazy as a senior cardiac surgeon making TikTok videos," said Dan Engelman at #EACTS2025. "But it turns out that’s what people watch. . . . And they want the message in one minute, it turns out, or less." #CardioSky

www.tctmd.com/news/educati...
Education Meets TikTok: Cardiac Surgeons Teach Patient Recovery in New Ways
Doctors might feel out of their element making the videos, but patients respond to the short, informative reels.
www.tctmd.com
October 15, 2025 at 7:22 PM
"Given the known bleeding risk with oral anticoagulants, the very low AF burden questions current ESC guidelines recommending long-term oral anticoagulation," said Florian Herrmann. #EACTS2025 #CardioSky

www.tctmd.com/news/nearly-...
Nearly Half of CABG Patients Have New-Onset AF, but It Often Doesn’t Last
Data from implantable monitors show a low AF burden with time, leading some to question the need for oral anticoagulation.
www.tctmd.com
October 13, 2025 at 8:53 PM
My first story from #EACTS2025 dives into a unique analysis comparing 5-year TAVI vs SAVR mortality that provoked some strong feelings about what type of research should inform guidelines. #CardioSky
www.tctmd.com/news/savr-be...
SAVR Bests TAVI for 5-Year Survival in Combined RCT, Observational Data
The findings sparked a debate about the merits of RCTs vs other study designs—one surgeon urged others to “read a textbook.”
www.tctmd.com
October 11, 2025 at 7:42 AM
Looking forward to being at #EACTS2025. Full coverage to come on @tctmd.bsky.social
October 9, 2025 at 11:38 AM
“The time-sensitive nature of transthyretin cardiomyopathy is something that has been on many people’s minds, but I think this is the first piece of evidence that should push us forward,” said Ahmad Masri, MD at #HFSA2025. #CardioSky
October 1, 2025 at 7:22 PM
Reposted by Yael L. Maxwell
In the phase III CELEBRATE trial, the novel injectable glycoprotein IIb/IIIa inhibitor zalunfiban has met its primary safety and efficacy outcomes in STEMI patients. Read more here: www.tctmd.com/news/celebra...
CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI
The drug met primary safety and efficacy outcomes, with full results to be presented at the AHA Scientific Sessions.
www.tctmd.com
September 30, 2025 at 2:32 PM
“You often learn from when science goes the opposite direction from what you expect,” said presenter David Berg, MD. The next question to answer is what role GDF-15 plays in heart failure. #HFSA2025 #CardioSky
October 1, 2025 at 1:13 PM
Another from #HFSA2025: this time looking at a new CCM-D device in patients with HFrEF. Will this be enough for CCM to gain traction in the HF world? #CardioSky
September 29, 2025 at 8:10 PM
My first from #HFSA2025 and an interesting one to boot! The Cordio HearO App can pick up signals of heart failure events more than 3 weeks before they happen. #CardioSky
September 29, 2025 at 6:23 PM
The first plenary session at #HFSA2025 is about to begin and all of my coverage will be on ⁦‪@tctmd.bsky.social!‬⁩ Who else is here and what are you looking forward to at the meeting?
September 27, 2025 at 1:54 PM
Reposted by Yael L. Maxwell
What's new in the world of cardiology? In this month's Heart Sounds, the TCTMD team highlights their favorite stories from September, and @DrRobRoswell joins to discuss DAPT-SHOCK-AMI. Full episode here: www.tctmd.com/audio/top-ca...

@yaelmaxwell.bsky.social
September 24, 2025 at 6:11 PM
Earlier, less invasive treatment is the name of the game according to new @escardio.bsky.social and @eacts.bsky.social valvular heart disease guidelines. #ESCongress

www.tctmd.com/news/esceact...
ESC/EACTS Release New Valvular Heart Disease Guidelines
Among the changes are a lower TAVI age cutoff and greater emphasis on patient education and coronary CTA.
www.tctmd.com
September 3, 2025 at 8:29 PM
Reposted by Yael L. Maxwell
On the latest On Record, @yaelmaxwell.bsky.social, Gilbert Tang, and Tsuyoshi Kaneko discuss reinterventions after TAVI during #NYValves2025. Watch the full video here: www.tctmd.com/videos/on-re...
August 18, 2025 at 7:02 PM
New US hypertension guidelines, the first since 2017, released today reinforce prior recs that prioritize lowering BP early and aggressively, with special emphasis on lifestyle, the connection between BP and cognitive function, and pregnancy. #CardioSky

www.tctmd.com/news/new-acc...
New ACC/AHA Hypertension Guidelines Still Urge Early Treatment but With Some Twists
The document, last updated in 2017, promotes use of the PREVENT calculator as well as more flexible BP goals.
www.tctmd.com
August 14, 2025 at 8:44 PM
Reposted by Yael L. Maxwell
During #NYValves2025, Patrick O'Gara, Michael Borger, and @yaelmaxwell.bsky.social discussed how the FDA approval of asymptomatic TAVI has changed practice, with perspectives from the US and Europe. Watch the full episode of On Record here: www.tctmd.com/videos/on-re...
August 7, 2025 at 5:46 PM
Reposted by Yael L. Maxwell
In this episode of Heart Sounds, our TCTMD journalists discuss the top news in cardiology for July. @lamckeown1.bsky.social @yaelmaxwell.bsky.social @toddneale.bsky.social www.tctmd.com/audio/top-ca...
July 31, 2025 at 6:08 PM
I set up a Signal account if anyone would prefer to reach me there.
July 31, 2025 at 5:42 PM
Whether a patient undergoes CAC screening depends on the type of doctor they see, with large sex differences observed over the past decade at a single healthcare system, according to retrospective data. #SCCT2025 #CardioSky

www.tctmd.com/news/cardiol...
Cardiologists More Often Send Higher-Risk Patients for CAC Scans vs Generalists
The decade-long, single-healthcare-system study gives insights into how physicians are using CAC tests and in which patients.
www.tctmd.com
July 30, 2025 at 3:14 PM
Intensive medical therapy usual care for reducing noncalcified coronary plaque in women who have INOCA, according to results of a serial imaging subanalysis of the WARRIOR trial. #SCCT2025 #CardioSky @damini-d.bsky.social

www.tctmd.com/news/less-pl...
Less Plaque With Intensive Medical Therapy vs Usual Care in INOCA: WARRIOR
The serial imaging substudy shows that intensive therapy might change plaque morphology positively, researchers say.
www.tctmd.com
July 29, 2025 at 1:52 PM
New in the @tctmd.bsky.social Fellows in Focus Feed: Attendees at #Fellows2025 tell us how they define success in medicine. #FellowsForum #CardioSKy

www.tctmd.com/videos/defin... @abdullahalabcha.bsky.social
Defining Success in Medicine
From patient satisfaction to making family and mentors proud, fellows tell TCTMD they feel fulfilled in a variety of ways.
www.tctmd.com
July 25, 2025 at 3:44 PM
Leaders in the field of cardiac CT celebrated 20 years of science, innovation, and overcoming challenges during a special session at the 2025 @scct-heart.bsky.social meeting. #SCCT2025 #CardioSky

www.tctmd.com/news/leaders...
Leaders in Cardiac CT Look Back on 20 Years of Growth Despite Challenges
A special session at SCCT was dedicated to the history of the field, but also explored future directions and unanswered questions.
www.tctmd.com
July 25, 2025 at 2:43 PM
AI-QCT can potentially improve preventive care for patients, especially women, thought to be at risk for ASCVD, according to an analysis of the CERTAIN study. #SCCT2025 #CardioSky

www.tctmd.com/news/ai-qct-...
AI-QCT Possibly Lessens Gap Between Ideal vs Actual Care for Patients at Risk of ASCVD
The “hypothesis-generating” results show that the technology might improve use of preventive therapies, especially in women.
www.tctmd.com
July 24, 2025 at 3:38 PM
For symptomatic patients who’ve undergone CCTA, added knowledge gleaned from AI-CPA (@heartflow.bsky.social) changes the management strategy more than half the time, according to new data from the DECIDE registry.

tctmd.com/news/ai-base...
@cianpmccarthy.bsky.social #SCCT2025 #Cardiosky
AI-Based Coronary Plaque Analysis Can Inform Management Beyond CCTA: DECIDE Registry
The technology, which led to a shift in strategy more than half of the time, could save $719 per symptomatic patient over 10 years.
tctmd.com
July 22, 2025 at 4:31 PM
Among more than 300 young, fit firefighters, CCTA led to 3.6% undergoing a diagnostic cath and 28.6% being referred to a cardiologist for medical or lifestyle management. Among the 2/3 with 0 CAC, 83% had noncalcified plaque. #SCCT2025 #CardioSky

www.tctmd.com/news/adding-...
Adding Coronary CT Angiography to Annual Firefighter Physicals Could Save Lives
Scanning identified significant CAD in this high-risk population, even among those with zero CAC.
www.tctmd.com
July 18, 2025 at 8:10 PM